|Series A, 2/2011 ||$12.1M|
|Series B, 1/2013 ||$9.5M|
|Partial Close, 12/2013 ||$5.8M|
Great Basin Corporation is a privately held life sciences company. Great Basin Corporation commercializes breakthrough technologies for the molecular, rapid diagnostic testing market.
Great Basin Corporation is dedicated to developing simple yet powerful point-of-care technology and products that improve automation, throughput, scalability, reliability and ease-of-use in rapid diagnostic testing.
Great Basin’s technology—providing greater scalability of content—will empower health providers to diagnose infectious disease and define a clear treatment path sooner for improved patient outcomes, shorter hospital stays, and dollars saved in hospitalization costs per patient. This next-generation technology will ultimately limit the spread of deadly hospital-acquired superbugs by delivering pinpoint accuracy to diagnosis, significantly reducing medication errors, false positives, and antibiotic drug resistance.
In short, we will bring this technology to doctors’ offices and pharmacies, making molecular testing so simple and cost effective that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease.
Please visit our Technology and Product pages to learn more about our innovative approach to diagnostics.